全文获取类型
收费全文 | 5989篇 |
免费 | 504篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 183篇 |
妇产科学 | 145篇 |
基础医学 | 844篇 |
口腔科学 | 100篇 |
临床医学 | 607篇 |
内科学 | 1083篇 |
皮肤病学 | 102篇 |
神经病学 | 563篇 |
特种医学 | 249篇 |
外科学 | 1040篇 |
综合类 | 106篇 |
一般理论 | 4篇 |
预防医学 | 543篇 |
眼科学 | 58篇 |
药学 | 321篇 |
中国医学 | 5篇 |
肿瘤学 | 501篇 |
出版年
2023年 | 36篇 |
2022年 | 68篇 |
2021年 | 132篇 |
2020年 | 86篇 |
2019年 | 148篇 |
2018年 | 166篇 |
2017年 | 109篇 |
2016年 | 138篇 |
2015年 | 147篇 |
2014年 | 191篇 |
2013年 | 284篇 |
2012年 | 410篇 |
2011年 | 401篇 |
2010年 | 207篇 |
2009年 | 204篇 |
2008年 | 322篇 |
2007年 | 355篇 |
2006年 | 274篇 |
2005年 | 256篇 |
2004年 | 256篇 |
2003年 | 218篇 |
2002年 | 220篇 |
2001年 | 143篇 |
2000年 | 140篇 |
1999年 | 131篇 |
1998年 | 53篇 |
1997年 | 60篇 |
1996年 | 44篇 |
1995年 | 53篇 |
1994年 | 38篇 |
1993年 | 31篇 |
1992年 | 101篇 |
1991年 | 88篇 |
1990年 | 111篇 |
1989年 | 93篇 |
1988年 | 74篇 |
1987年 | 76篇 |
1986年 | 81篇 |
1985年 | 63篇 |
1984年 | 53篇 |
1983年 | 41篇 |
1982年 | 31篇 |
1981年 | 28篇 |
1979年 | 40篇 |
1978年 | 29篇 |
1977年 | 21篇 |
1976年 | 22篇 |
1975年 | 22篇 |
1974年 | 30篇 |
1972年 | 21篇 |
排序方式: 共有6509条查询结果,搜索用时 15 毫秒
991.
Methicillin-resistant Staphylococcus aureus (MRSA) isolates that are susceptible to vancomycin but are tolerant to its killing effect may present a potential challenge for effective treatment. This study compared the microbiologic characteristics of clinical vancomycin-tolerant (VT-MRSA) and vancomycin-susceptible (VS-MRSA) strains using phenotypic and gene regulation studies. MRSA isolates collected from vancomycin-treated patients with bacteremia over a 5-year period were analyzed for vancomycin, daptomycin, and telavancin susceptibility, as well as accessory gene regulator (agr) group and function. Vancomycin tolerance was defined by a minimum bactericidal concentration (MBC)/minimum inhibitor concentration (MIC) ratio of ≥32 mg/liter. VT-MRSA isolates were compared to VS-MRSA isolates for differences in antimicrobial susceptibility, time-kill activity, and gene expression of key cell envelope response genes vraSR, dltA, and mprF. All 115 isolates evaluated were susceptible to vancomycin, daptomycin, and telavancin. Seven isolates (6%) were VT-MRSA. agr group II was more prevalent in isolates with vancomycin MBC/MIC ratios of ≥8. In time-kill analyses, VT-MRSA had reduced vancomycin killing, but daptomycin and telavancin activities were maintained. Significantly greater gene expression was observed in VT-MRSA after 72 h of subinhibitory antibiotic exposures. Vancomycin most notably increased vraSR expression (P = 0.002 versus VS-MRSA strains). Daptomycin and telavancin increased expression of all genes studied, most significantly mprF expression (P < 0.001). Longer durations of antibiotic exposure (72 h versus 24 h) resulted in substantial increases in gene expression in VT-MRSA. Although the clinical impact of VT-MRSA is not fully recognized, these data suggest that VT-MRSA strains, while still susceptible, have altered gene regulation to adapt to the antimicrobial effects of glyco- and lipopeptides that may emerge during prolonged durations of exposure. 相似文献
992.
993.
Sun C Pye SD Browne JE Janeczko A Ellis B Butler MB Sboros V Thomson AJ Brewin MP Earnshaw CH Moran CM 《Ultrasound in medicine & biology》2012,38(7):1262-1270
This study characterized the acoustic properties of an International Electromechanical Commission (IEC) agar-based tissue mimicking material (TMM) at ultrasound frequencies in the range 10–47 MHz. A broadband reflection substitution technique was employed using two independent systems at 21°C ± 1°C. Using a commercially available preclinical ultrasound scanner and a scanning acoustic macroscope, the measured speeds of sound were 1547.4 ± 1.4 m?s−1 and 1548.0 ± 6.1 m?s−1, respectively, and were approximately constant over the frequency range. The measured attenuation (dB?cm−1) was found to vary with frequency f (MHz) as 0.40f + 0.0076f2. Using this polynomial equation and extrapolating to lower frequencies give values comparable to those published at lower frequencies and can estimate the attenuation of this TMM in the frequency range up to 47 MHz. This characterisation enhances understanding in the use of this TMM as a tissue equivalent material for high frequency ultrasound applications. 相似文献
994.
995.
Nickel-chromium (Ni-Cr) alloys used in fixed prosthodontics have been associated with type IV Ni-induced hypersensitivity. We hypothesised that the full-thickness human-derived oral mucosa model employed for biocompatibility testing of base-metal dental alloys would provide insights into the mechanisms of Ni-induced toxicity. Primary oral keratinocytes and gingival fibroblasts were seeded onto Alloderm™ and maintained until full thickness was achieved prior to Ni-Cr and cobalt-chromium (Co-Cr) alloy disc exposure (2-72 h). Biocompatibility assessment involved histological analyses with cell viability measurements, oxidative stress responses, inflammatory cytokine expression and cellular toxicity analyses. Inductively coupled plasma mass spectrometry analysis determined elemental ion release levels. We detected adverse morphology with significant reductions in cell viability, significant increases in oxidative stress, inflammatory cytokine expression and cellular toxicity for the Ni-Cr alloy-treated oral mucosal models compared with untreated oral mucosal models, and adverse effects were increased for the Ni-Cr alloy that leached the most Ni. Co-Cr demonstrated significantly enhanced biocompatibility compared with Ni-Cr alloy-treated oral mucosal models. The human-derived full-thickness oral mucosal model discriminated between dental alloys and provided insights into the mechanisms of Ni-induced toxicity, highlighting potential clinical relevance. 相似文献
996.
Lamb AN Rosenfeld JA Neill NJ Talkowski ME Blumenthal I Girirajan S Keelean-Fuller D Fan Z Pouncey J Stevens C Mackay-Loder L Terespolsky D Bader PI Rosenbaum K Vallee SE Moeschler JB Ladda R Sell S Martin J Ryan S Jones MC Moran R Shealy A Madan-Khetarpal S McConnell J Surti U Delahaye A Heron-Longe B Pipiras E Benzacken B Passemard S Verloes A Isidor B Le Caignec C Glew GM Opheim KE Descartes M Eichler EE Morton CC Gusella JF Schultz RA Ballif BC Shaffer LG 《Human mutation》2012,33(4):728-740
997.
Germann M Wetterwald A Guzmán-Ramirez N van der Pluijm G Culig Z Cecchini MG Williams ED Thalmann GN 《Stem cells (Dayton, Ohio)》2012,30(6):1076-1086
Castration is the standard therapy for advanced prostate cancer (PC). Although this treatment is initially effective, tumors invariably relapse as incurable, castration-resistant PC (CRPC). Adaptation of androgen-dependent PC cells to an androgen-depleted environment or selection of pre-existing, CRPC cells have been proposed as mechanisms of CRPC development. Stem cell (SC)-like PC cells have been implicated not only as tumor initiating/maintaining in PC but also as tumor-reinitiating cells in CRPC. Recently, castration-resistant cells expressing the NK3 homeobox 1 (Nkx3-1) (CARNs), the other luminal markers cytokeratin 18 (CK18) and androgen receptor (AR), and possessing SC properties, have been found in castrated mouse prostate and proposed as the cell-of-origin of CRPC. However, the human counterpart of CARNs has not been identified yet. Here, we demonstrate that in the human PC xenograft BM18, pre-existing SC-like and neuroendocrine (NE) PC cells are selected by castration and survive as totally quiescent. SC-like BM18 cells, displaying the SC markers aldehyde dehydrogenase 1A1 or NANOG, coexpress the luminal markers NKX3-1, CK18, and a low level of AR (AR(low)) but not basal or NE markers. These CR luminal SC-like cells, but not NE cells, reinitiate BM18 tumor growth after androgen replacement. The AR(low) seems to mediate directly both castration survival and tumor reinitiation. This study identifies for the first time in human PC SC-/CARN-like cells that may represent the cell-of-origin of tumor reinitiation as CRPC. This finding will be fundamental for refining the hierarchy among human PC cancer cells and may have important clinical implications. 相似文献
998.
999.
1000.
Weinstein T Evron Z Trebicz-Geffen M Aviv M Robinson D Kollander Y Nevo Z 《Connective tissue research》2012,53(2):169-179
The familial disease of hereditary multiple exostoses is characterized by abnormal skeletal deformities requiring extensive surgical procedures. In hereditary multiple exostoses patients there is a shortage in the pericellular glycosaminoglycan (GAG) of heparan sulfate (HS), related to defective activity of HS glycosyltransferases, mainly in the pericellular regions of chondrocytes. This study searched for a novel approach employing xylosides with different aglycone groups priming a variety of GAG chains, in attempting to alter the GAG compositional profile. Cell cultures of patients with osteochondroma responded to p-nitrophenyl β-D-xyloside by a significant increase in total GAG synthesis, expressed mainly in the extracellular domains, limited to chondroitin sulfate). The different β-D-xylosides, in addition to increasing the synthesis of extracellular GAGs, led to a significant depletion of the intracellular GAG domains. In mouse chondrocyte cultures, β-D-xylosides with different aglycones created a unique distribution of the GAG pools. Of special interest was the finding that the naphthalene methanol β-D-xyloside showed the highest absolute levels of HS-GAGs in both extracellular and intra-pericellular moieties compared with other β-D-xylosides and with controls without xyloside. In summary, β-D-xylosides can be utilized in chondrocyte cultures to modify the distribution of GAGs between the extracellular and intracellular compartments. In addition, xylosides may alter the profile of specific GAG chains in each moiety. 相似文献